Go Pro
→ Central banks bought 710 tonnes - this fund pays monthly (From Investors Alley) (Ad)tc pixel Free ONC Stock Alerts

BeOne Medicines (ONC) Earnings Date, Estimates & Call Transcripts

BeOne Medicines logo
$356.01 -3.04 (-0.85%)
Closing price 08/13/2026 04:00 PM Eastern
Extended Trading
$349.66 -6.35 (-1.78%)
As of 06:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BeOne Medicines Earnings Summary

BeOne Medicines announced Q2 2026 earnings on August 5, 2026, reporting an EPS of $2.05, which beat analysts' consensus estimates of $1.40 by $0.65. Quarterly revenue was reported to be $1.71 billion, above the consensus estimate of $1.66 billion. With a trailing EPS of $5.68 and a P/E Ratio of 62.68, BeOne Medicines' earnings are expected to grow 52.33% next year, from $7.30 to $11.12 per share.

Latest Q2
Earnings Date
Aug. 5Confirmed
Consensus EPS
(Aug. 5)
$1.40
Actual EPS
(Aug. 5)
$2.05 Beat By $0.65
Actual Revenue
(Aug. 5)
$1.71B

Q2 2026 Earnings Resources

Slide Deck

BeOne Medicines' Q2 2026 Slide DeckFull Screen Slide Deck
Powered by Quartr
Get BeOne Medicines Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BeOne Medicines and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ONC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ONC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BeOne Medicines Analyst EPS Estimates

Current Year EPS Consensus Estimate
$7.30 EPS
Next Year EPS Consensus Estimate
$11.12 EPS

BeOne Medicines Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026$1.40$2.05+$0.65$2.05$1.66B$1.71B
4/1/2026Q1 2026-$0.25-$1.95-$1.51B
2/26/2026Q4 2025$1.60$0.58 -$1.02$0.58$1.45B$1.50B
8/6/2025Q2 2025$0.48$0.84+$0.36$0.84$1.24B$1.32B
5/7/2025Q1 2025-$0.71$1.22+$1.93$0.01$1.12B$1.12B
2/27/2025Q4 2024-$0.88-$1.43 -$0.55-$1.43$1.09B$1.13B

BeOne Medicines Earnings - Frequently Asked Questions

BeOne Medicines (NASDAQ:ONC) last announced its quarterly earning data on Wednesday, August 5, 2026. Learn more on ONC's earnings history.

BeOne Medicines updated its FY 2026 earnings guidance on Wednesday, August, 5th. The company issued revenue guidance of $6.6 billion-$6.8 billion, compared to the consensus revenue estimate of $6.5 billion.

In the previous quarter, BeOne Medicines (NASDAQ:ONC) reported $2.05 earnings per share (EPS) to beat the analysts' consensus estimate of $1.40 by $0.65. Learn more on analysts' earnings estimate vs. ONC's actual earnings.

The conference call for BeOne Medicines' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for BeOne Medicines' latest earnings report can be read online.
Read Transcript

BeOne Medicines (NASDAQ:ONC) has a recorded annual revenue of $5.34 billion.

BeOne Medicines (NASDAQ:ONC) has a recorded net income of $286.93 million. ONC has generated $5.68 earnings per share over the last four quarters.

BeOne Medicines (NASDAQ:ONC) has a trailing price-to-earnings ratio of 62.68 and a forward price-to-earnings ratio of 48.77.

BeOne Medicines' earnings are expected to grow from $7.30 per share to $11.12 per share in the next year, which is a 52.33% increase.

Related Companies
Earnings Tools

Earnings data for NASDAQ:ONC is sourced from Fiscal.ai, with the most recent quarter reported on 8/5/2026. New results are added as companies report their earnings.
From Our Partners
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Central banks bought 710 tonnes - this fund pays monthly
Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Gold buyout deals have handed shareholders overnight gains up to 79 percent
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...
Golden Portfolio | Sponsoredtc pixel